Palantir’s (PLTR) 4Q adjusted EPS came in at $0.08 versus an estimated $0.08 and revenue came in at $602.41M versus an estimated $603.48M. Vertex Pharmaceuticals’ (VRTX) 4Q adjusted EPS came in at $4.20 versus an estimated $4.08 and revenue came in at $2.52B versus an estimated $2.50B. NXP Semiconductor’s (NXPI) 4Q adjusted EPS came in at $3.71 versus an estimated $3.64 and revenue came in at $3.42B versus an estimated $3.40B. Diane King Hall and Kevin Green discuss these earnings.